Top Tweets for #AFT70

Komal Jhaveri, MD, FACP, FASCO @jhaveri_komal

7 days ago

Can we spare CDK4/6i in ER+ early breast cancer and escalate only when needed? #AFT70 NAVIGATE: giredestrant + serial MRD monitoring, with CDK4/6i added only if MRD turns +ve. 2,000+ pts, ~200 sites. Risk-adapted, not one-size-fits-all. @guptalabunc @MSKCancerCenter @OncoAlert

Alliance for Clinical Trials in Oncology @ALLIANCE_org

8 days ago

Alliance Foundation Trials and Natera have launched AFT-70 NAVIGATE, a global Phase III trial in ER+/HER2- early-stage breast cancer, evaluating giredestrant, Genentech’s investigational oral SERD, with Signatera™ MRD-guided CDK4/6 inhibitor therapy: https://t.co/OpUPjsSkGi

Top Tweets for #AFT70

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users